Barclays raises QIAGEN to overweight from equal-weight, lifts target price to $55 from $40
QGEN•Barclays raised its rating on QIAGEN to overweight from equal-weight and increased its target price to $55 from $40.
Related News
Willdan Group initiates coverage with outperform rating; target price $100.00
WLDN•
Yorkville Ives initiates coverage of Zscaler with outperform rating and $250 target
ZS•
Serve Robotics initiates coverage with outperform rating and $8 target
SERV•
Yorkville initiates coverage of Salesforce with outperform rating and $290 target
CRM•
Rocket Pharmaceuticals: Leerink Partners cuts target price to $4 from $7
RCKT•